A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5

類似資料

• HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4(+) T Cells
  著者:: Pfaff, Jennifer M., 等
  出版事項: (2010)
• Multifaceted Mechanisms of HIV Inhibition and Resistance to CCR5 Inhibitors PSC-RANTES and Maraviroc
  著者:: Lobritz, Michael A., 等
  出版事項: (2013)
• Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry
  著者:: Westby, Mike, 等
  出版事項: (2007)
• Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor
  著者:: Jiang, Xiaowei, 等
  出版事項: (2015)
• Preparation and Activities of Macromolecule Conjugates of the CCR5 Antagonist Maraviroc
  著者:: Asano, Shigehiro, 等
  出版事項: (2013)